Enhancing Community Participation Through Peer-Delivered Decision Support
Launched by TEMPLE UNIVERSITY · Jul 2, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new program called "peer decision coaching" to help young adults with serious mental illnesses, like schizophrenia or major depression, make better choices about getting involved in their communities. The goal is to support participants in identifying activities they want to participate in more, such as work, school, or social events, and help them improve their engagement in these areas.
To be eligible for the study, participants need to be between 18 and 30 years old and have a history of mental health challenges that affect their daily lives. They should also be able to name at least two community activities they wish to pursue more in the next six months and currently participate in less than half of the important activities they want to engage in. If you decide to join, you will receive support from peers—people who understand your experiences—to help you make decisions and take steps towards greater community participation. The trial is currently looking for participants, and they will assess your ability to understand and consent to the study before you enroll.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-30 years of age;
- • Experiencing a SMI, as determined by: (a) self-reported psychiatric diagnosis of schizophrenia-spectrum or major affective disorder, and (b) self-reported current or past functional impairment due to experiencing mental health challenges in one or more major life areas (i.e., work school, social activities)
- • Able to identify at least 2 areas of community participation that individuals want to be doing more in in the next 6 months
- • Current sufficiency of community participation (i.e., number of important participation areas done enough / number of important participation areas) of 50% or less.
- Exclusion Criteria:
- • Unable to provide informed consent, as assessed by research staff using an active recall method
- • limited ability to act on decisions due to self-reported legal, residential, or guardianship restrictions.
About Temple University
Temple University is a leading academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to research and innovation in the health sciences. As a clinical trial sponsor, Temple University leverages its extensive resources, including a diverse pool of participants and cutting-edge facilities, to advance medical knowledge and improve patient care. The university's clinical research initiatives are driven by a multidisciplinary team of experts dedicated to conducting high-quality studies that address critical health issues and contribute to the development of novel therapies. Through its partnerships with local and global organizations, Temple University aims to enhance the translation of research findings into practical applications that benefit communities and advance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Brattleboro, Vermont, United States
Patients applied
Trial Officials
Elizabeth Thomas, PhD
Principal Investigator
Temple University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported